AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 33187116 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioral-activation conference call intervention (BACC)
Number of subjects: 219
Study 33187116 — intervention group
Group type: COMPARATOR
Intervention: Usual care control group (CG)
Number of subjects: 219
Study 35793732 — intervention group
Group type: EXPERIMENTAL
Intervention: Phone-only visits
Number of subjects: 200
Study 35793732 — intervention group
Group type: COMPARATOR
Intervention: Video visits
Number of subjects: 200
Study 35793732 — intervention group
Group type: EXPERIMENTAL
Intervention: Both interventions
Number of subjects: 200
Study 34593022 — intervention group
Group type: EXPERIMENTAL
Intervention: Contralateral exploration during unilateral hernia repair
Number of subjects: 378
Study 34593022 — intervention group
Group type: COMPARATOR
Intervention: No contralateral exploration during unilateral hernia repair
Number of subjects: 378
Study 32428620 — intervention group
Group type: EXPERIMENTAL
Intervention: simplified LBBaP (s‐LBBaP)
Number of subjects: 51
Study 32428620 — intervention group
Group type: COMPARATOR
Intervention: conventional LBBaP (c‐LBBaP)
Number of subjects: 51
Study 32428620 — intervention group
Group type: EXPERIMENTAL
Intervention: s‐LBBaP
Number of subjects: 51
Study 35150301 — intervention group
Group type: EXPERIMENTAL
Intervention: Speed of Processing Training (SOPT)
Number of subjects: 84
Study 35150301 — intervention group
Group type: COMPARATOR
Intervention: Placebo Control
Number of subjects: 84
Study 34082905 — intervention group
Group type: EXPERIMENTAL
Intervention: Percutaneous coronary intervention (PCI)
Number of subjects: 575
Study 34082905 — intervention group
Group type: EXPERIMENTAL
Intervention: Coronary artery bypass graft (CABG)
Number of subjects: 575
Study 34082905 — intervention group
Group type: EXPERIMENTAL
Intervention: Life expectancy
Number of subjects: 575
Study 34082905 — intervention group
Group type: EXPERIMENTAL
Intervention: Quality of life (QOL) status
Number of subjects: 575
Study 32378922 — intervention group
Group type: EXPERIMENTAL
Intervention: 4-week mindfulness-based training (MBT)
Number of subjects: 61
Study 32378922 — intervention group
Group type: COMPARATOR
Intervention: 4-week adaptive cognitive training (aCT)
Number of subjects: 61
Study 32378922 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control group
Number of subjects: 61
Study 34753425 — intervention group
Group type: EXPERIMENTAL
Intervention: TMQLB with 0.4 ml/kg 0.5% ropivacaine
Number of subjects: 72
Study 34753425 — intervention group
Group type: COMPARATOR
Intervention: 0.9% saline as placebo
Number of subjects: 72
Study 32335605 — intervention group
Group type: EXPERIMENTAL
Intervention: Medical Abortion
Number of subjects: 160
Study 32335605 — intervention group
Group type: COMPARATOR
Intervention: Manual Vacuum Aspiration
Number of subjects: 160
Study 34374766 — intervention group
Group type: EXPERIMENTAL
Intervention: Dronedarone
Number of subjects: 6797
Study 34374766 — intervention group
Group type: COMPARATOR
Intervention: Dronedarone vs. Placebo
Number of subjects: 6797
Study 34717741 — intervention group
Group type: EXPERIMENTAL
Intervention: Liposuction
Number of subjects: 405
Study 34717741 — intervention group
Group type: COMPARATOR
Intervention: Complex decongestive therapy (CDT)
Number of subjects: 405
Study 33151313 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline serum neurofilament light concentration
Number of subjects: 308
Study 33151313 — intervention group
Group type: EXPERIMENTAL
Intervention: Highest vs lowest baseline serum neurofilament light tertiles
Number of subjects: 308
Study 33151313 — intervention group
Group type: COMPARATOR
Intervention: Highest neurofilament tertile
Number of subjects: 308
Study 33151313 — intervention group
Group type: COMPARATOR
Intervention: Lowest neurofilament tertile
Number of subjects: 308
Study 35766355 — intervention group
Group type: EXPERIMENTAL
Intervention: Deep brain stimulation (DBS) targeting the globus pallidus internus/externus
Number of subjects: 0
Study 35766355 — intervention group
Group type: EXPERIMENTAL
Intervention: Stereotactic brain grafting
Number of subjects: 0
Study 33899971 — intervention group
Group type: EXPERIMENTAL
Intervention: Endurance Training (END)
Number of subjects: 35
Study 33899971 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance Training (RT)
Number of subjects: 35
Study 33899971 — intervention group
Group type: COMPARATOR
Intervention: Both END and RT
Number of subjects: 35
Study 35508923 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 g beetroot (272 mg NO3‐)
Number of subjects: 24
Study 35508923 — intervention group
Group type: EXPERIMENTAL
Intervention: 200 g beetroot (544 mg NO3‐)
Number of subjects: 24
Study 35508923 — intervention group
Group type: EXPERIMENTAL
Intervention: 300 g beetroot (816 mg NO3‐)
Number of subjects: 24
Study 35508923 — intervention group
Group type: EXPERIMENTAL
Intervention: 200-ml solution containing 1000 mg potassium nitrate (KNO3)
Number of subjects: 24
Study 34404091 — intervention group
Group type: EXPERIMENTAL
Intervention: Local vibration therapy (VT)
Number of subjects: 10
Study 34404091 — intervention group
Group type: COMPARATOR
Intervention: Control (CON)
Number of subjects: 10
Study 32493288 — intervention group
Group type: EXPERIMENTAL
Intervention: Cisplatin low cumulative dose (≤150 mg/m2)
Number of subjects: 779
Study 32493288 — intervention group
Group type: EXPERIMENTAL
Intervention: Cisplatin intermediate cumulative dose (151-250 mg/m2)
Number of subjects: 779
Study 32493288 — intervention group
Group type: EXPERIMENTAL
Intervention: Cisplatin high cumulative dose (>250 mg/m2)
Number of subjects: 779
Study 32493288 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall population (all cumulative doses)
Number of subjects: 779
Study 34182575 — intervention group
Group type: EXPERIMENTAL
Intervention: Scabies (91 adults, 103 children)
Number of subjects: 1655
Study 34182575 — intervention group
Group type: COMPARATOR
Intervention: Control group (participants without skin disease)
Number of subjects: 1655
Study 34639692 — intervention group
Group type: EXPERIMENTAL
Intervention: Fitness app usage (experimental group)
Number of subjects: 66
Study 34639692 — intervention group
Group type: COMPARATOR
Intervention: Control group (no fitness app usage)
Number of subjects: 66
Study 32396914 — intervention group
Group type: EXPERIMENTAL
Intervention: Lavender oil application
Number of subjects: 68
Study 32396914 — intervention group
Group type: COMPARATOR
Intervention: Control group (no lavender oil)
Number of subjects: 68
Study 33100327 — intervention group
Group type: EXPERIMENTAL
Intervention: Gemcitabine-based chemoradiotherapy (CRT)
Number of subjects: 60
Study 33100327 — intervention group
Group type: COMPARATOR
Intervention: Capecitabine-based chemoradiotherapy (CRT)
Number of subjects: 60
Study 35103059 — intervention group
Group type: EXPERIMENTAL
Intervention: Bromhexine hydrochloride (8 mg 3 times per day)
Number of subjects: 50
Study 35103059 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 50
Study 32104959 — intervention group
Group type: EXPERIMENTAL
Intervention: Palatal augmentation prostheses (PAP)
Number of subjects: 20
Study 35554758 — intervention group
Group type: EXPERIMENTAL
Intervention: Immuno-sympathoinhibitory EA treatment
Number of subjects: 21
Study 35554758 — intervention group
Group type: COMPARATOR
Intervention: Sympathoinhibitory EA treatment
Number of subjects: 21
Study 33065060 — intervention group
Group type: EXPERIMENTAL
Intervention: Canagliflozin (100 mg)
Number of subjects: 4401
Study 33065060 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 4401
Study 34308900 — intervention group
Group type: EXPERIMENTAL
Intervention: e-Health intervention
Number of subjects: 0
Study 34308900 — intervention group
Group type: COMPARATOR
Intervention: Usual home program (control)
Number of subjects: 0
Study 33221865 — intervention group
Group type: EXPERIMENTAL
Intervention: Cross-lagged twin-differences analyses
Number of subjects: 2386
Study 33221865 — intervention group
Group type: EXPERIMENTAL
Intervention: Polygenic score (PS) analyses
Number of subjects: 2386
Study 33221865 — intervention group
Group type: EXPERIMENTAL
Intervention: Mendelian randomization (MR) analyses
Number of subjects: 2386
Study 33221865 — intervention group
Group type: EXPERIMENTAL
Intervention: Multivariable MR
Number of subjects: 2386
Study 32406767 — intervention group
Group type: EXPERIMENTAL
Intervention: Verbal and visual demonstrations on OFSP-based foods
Number of subjects: 764
Study 32406767 — intervention group
Group type: COMPARATOR
Intervention: Verbal demonstrations on OFSP-based foods
Number of subjects: 764
Study 33118636 — intervention group
Group type: EXPERIMENTAL
Intervention: Edoxaban (low-dose: 15 and 30 mg)
Number of subjects: 346
Study 33152408 — intervention group
Group type: EXPERIMENTAL
Intervention: Two-unit cantilevered RBFPD (CL2)
Number of subjects: 83
Study 33152408 — intervention group
Group type: COMPARATOR
Intervention: Three-unit fixed-movable RBFPD (FM3)
Number of subjects: 83
Study 33152408 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient-reported outcomes (satisfaction and OHIP-49 scores) for both CL2 and FM3
Number of subjects: 83
Study 32887548 — intervention group
Group type: EXPERIMENTAL
Intervention: Fremanezumab (quarterly or monthly)
Number of subjects: 1842
Study 32887548 — intervention group
Group type: EXPERIMENTAL
Intervention: Fremanezumab
Number of subjects: 1842
Study 33358708 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-Level Laser Photobiomodulation
Number of subjects: 0
Study 33358708 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study 32972868 — intervention group
Group type: EXPERIMENTAL
Intervention: Health coaching intervention (3 telephonic calls by an unlicensed, trained health coach)
Number of subjects: 131
Study 32972868 — intervention group
Group type: EXPERIMENTAL
Intervention: Health coaching intervention
Number of subjects: 131
Study 32972868 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 131
Study 34118115 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 mg DPV ring
Number of subjects: 49
Study 34118115 — intervention group
Group type: EXPERIMENTAL
Intervention: 200 mg DPV ring
Number of subjects: 49
Study 34118115 — intervention group
Group type: COMPARATOR
Intervention: Monthly 25 mg DPV ring
Number of subjects: 49
Study 616738771 — intervention group
Group type: EXPERIMENTAL
Intervention: Immunization training intervention (two-day training)
Number of subjects: 70
Study 616738771 — intervention group
Group type: COMPARATOR
Intervention: Control group (no training)
Number of subjects: 70
Study 35260544 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-fidelity simulator group (LFSG)
Number of subjects: 121
Study 35260544 — intervention group
Group type: EXPERIMENTAL
Intervention: Video training group (VTG)
Number of subjects: 121
Study 35260544 — intervention group
Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 121
Study 35099430 — intervention group
Group type: EXPERIMENTAL
Intervention: Mulligan mobilisation with movement
Number of subjects: 64
Study 35099430 — intervention group
Group type: COMPARATOR
Intervention: Muscle energy technique
Number of subjects: 64
Study 34518109 — intervention group
Group type: EXPERIMENTAL
Intervention: Telephone counseling based on the IMB model
Number of subjects: 63
Study 34518109 — intervention group
Group type: COMPARATOR
Intervention: No intervention
Number of subjects: 63
Study 32028780 — intervention group
Group type: EXPERIMENTAL
Intervention: Sluggish cognitive tempo assessment
Number of subjects: 57
Study 34967126 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-sodium salt (LS) substitution
Number of subjects: 352
Study 34967126 — intervention group
Group type: COMPARATOR
Intervention: Normal salt (NS)
Number of subjects: 352
Study 34344273 — intervention group
Group type: EXPERIMENTAL
Intervention: Standardized educational intervention on cancer pain management and analgesics (10-15 minutes)
Number of subjects: 100
Study 35395427 — intervention group
Group type: COMPARATOR
Intervention: Conservative management (n = 81)
Number of subjects: 403
Study 35395427 — intervention group
Group type: EXPERIMENTAL
Intervention: Curative treatment (n = 78)
Number of subjects: 403
Study 35395427 — intervention group
Group type: EXPERIMENTAL
Intervention: Endovascular treatment (17 patients)
Number of subjects: 403
Study 35395427 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgery (2 patients)
Number of subjects: 403
Study 35395427 — intervention group
Group type: EXPERIMENTAL
Intervention: RCT comparing endovascular with surgical treatment (20 patients)
Number of subjects: 403
Study 33181169 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcutaneous application of gaseous CO2 (CO2 therapy) for 4 weeks
Number of subjects: 42
Study 33181169 — intervention group
Group type: COMPARATOR
Intervention: Placebo treatment with transcutaneous application of air for 4 weeks
Number of subjects: 42
Study 36216918 — intervention group
Group type: EXPERIMENTAL
Intervention: Upper eyelid blepharoplasty (UEB) surgery
Number of subjects: 90
Study 36216918 — intervention group
Group type: COMPARATOR
Intervention: Dermatochalasis (DC)
Number of subjects: 90
Study 36102914 — intervention group
Group type: EXPERIMENTAL
Intervention: Sentinel Lymph Node Biopsy
Number of subjects: 0
Study 36102914 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study 33464301 — intervention group
Group type: EXPERIMENTAL
Intervention: Motor Skill Training in Functional Activities
Number of subjects: 0
Study 33464301 — intervention group
Group type: COMPARATOR
Intervention: Strength and Flexibility Exercise
Number of subjects: 0
Study 33379253 — intervention group
Group type: EXPERIMENTAL
Intervention: LGIMD plus PA1
Number of subjects: 144
Study 33379253 — intervention group
Group type: EXPERIMENTAL
Intervention: LGIMD plus PA2
Number of subjects: 144
Study 33379253 — intervention group
Group type: COMPARATOR
Intervention: Control diet
Number of subjects: 144
Study 35057599 — intervention group
Group type: EXPERIMENTAL
Intervention: Tofacitinib (10 mg for 14 days)
Number of subjects: 100
Study 35057599 — intervention group
Group type: COMPARATOR
Intervention: Standard of Care (SOC) treatment alone
Number of subjects: 100
Study 32134320 — intervention group
Group type: EXPERIMENTAL
Intervention: weekly written feedback individualized by a counselor
Number of subjects: 1089
Study 32134320 — intervention group
Group type: COMPARATOR
Intervention: automated and fully standardized feedback
Number of subjects: 1089
Study 35486012 — intervention group
Group type: EXPERIMENTAL
Intervention: Eye acupuncture
Number of subjects: 90
Study 35486012 — intervention group
Group type: COMPARATOR
Intervention: Exercise therapy
Number of subjects: 90
Study 35486012 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined treatment (eye acupuncture + exercise therapy)
Number of subjects: 90
Study 34544182 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactate-guided therapy
Number of subjects: 0
Study 34544182 — intervention group
Group type: COMPARATOR
Intervention: Normalizing capillary refill time
Number of subjects: 0
Study 33561963 — intervention group
Group type: EXPERIMENTAL
Intervention: Monthly high-dose vitamin D supplementation (initial dose of 200,000 IU vitamin D3 followed by 100,000 IU monthly)
Number of subjects: 775
Study 33561963 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 775
Study 33561963 — intervention group
Group type: EXPERIMENTAL
Intervention: Monthly high-dose vitamin D supplementation
Number of subjects: 775
Study 32151236 — intervention group
Group type: EXPERIMENTAL
Intervention: Robotic therapy (ReoGeo system) plus standard therapy
Number of subjects: 56
Study 32151236 — intervention group
Group type: COMPARATOR
Intervention: Self-guided therapy plus standard therapy
Number of subjects: 56
Study 32151236 — intervention group
Group type: EXPERIMENTAL
Intervention: Robotic therapy
Number of subjects: 56
Study 32151236 — intervention group
Group type: COMPARATOR
Intervention: Self-guided therapy
Number of subjects: 56
Study 35074433 — intervention group
Group type: EXPERIMENTAL
Intervention: DWI-guided dose-painting intensity modulated radiation therapy (DP-IMRT)
Number of subjects: 260
Study 35074433 — intervention group
Group type: COMPARATOR
Intervention: Conventional MRI-based IMRT
Number of subjects: 260
Study 33627312 — intervention group
Group type: EXPERIMENTAL
Intervention: Screening by clinical breast examination (4 rounds every 2 years)
Number of subjects: 151538
Study 33627312 — intervention group
Group type: EXPERIMENTAL
Intervention: Screening by clinical breast examination
Number of subjects: 151538
Study 36310299 — intervention group
Group type: EXPERIMENTAL
Intervention: Regorafenib
Number of subjects: 147
Study 36310299 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 147
Study 36310299 — intervention group
Group type: COMPARATOR
Intervention: Site assessments
Number of subjects: 147
Study 36310299 — intervention group
Group type: COMPARATOR
Intervention: Post-progression unblinding
Number of subjects: 147
Study 34536601 — intervention group
Group type: EXPERIMENTAL
Intervention: Nodal regression system (Tsekrekos grading)
Number of subjects: 47
Study 35566482 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous Ferric Carboxymaltose (FCM)
Number of subjects: 110
Study 35566482 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 110
Study 34419615 — intervention group
Group type: EXPERIMENTAL
Intervention: ECGio (artificial intelligence algorithm)
Number of subjects: 1659
Study 32298131 — intervention group
Group type: EXPERIMENTAL
Intervention: Bridge-Enhanced ACL Repair (BEAR)
Number of subjects: 100
Study 32298131 — intervention group
Group type: COMPARATOR
Intervention: Autograft ACL Reconstruction (ACLR)
Number of subjects: 100
Study 35465014 — intervention group
Group type: EXPERIMENTAL
Intervention: Rehabilitation nursing under the guidance of the HAPA model
Number of subjects: 200
Study 35465014 — intervention group
Group type: COMPARATOR
Intervention: Routine nursing
Number of subjects: 200
Study 34292204 — intervention group
Group type: EXPERIMENTAL
Intervention: 50 mg of oral naltrexone (n = 42)
Number of subjects: 82
Study 34292204 — intervention group
Group type: COMPARATOR
Intervention: Placebo (n = 40)
Number of subjects: 82
Study 32703511 — intervention group
Group type: EXPERIMENTAL
Intervention: Implantable cardioverter-defibrillator (ICD) therapy
Number of subjects: 2521
Study 32703511 — intervention group
Group type: COMPARATOR
Intervention: Amiodarone
Number of subjects: 2521
Study 34160113 — intervention group
Group type: EXPERIMENTAL
Intervention: Fermented rapeseed meal (FRSM)
Number of subjects: 420
Study 34160113 — intervention group
Group type: COMPARATOR
Intervention: 15% Raw rapeseed meal (RRSM)
Number of subjects: 420
Study 34160113 — intervention group
Group type: EXPERIMENTAL
Intervention: Fermented rapeseed meal (FRSM) and Raw rapeseed meal (RRSM)
Number of subjects: 420
Study 34160113 — intervention group
Group type: EXPERIMENTAL
Intervention: 10% Fermented rapeseed meal (FRSM) and 10% Raw rapeseed meal (RRSM)
Number of subjects: 420
Study 33098212 — intervention group
Group type: EXPERIMENTAL
Intervention: Simultaneous pump and CGM initiation offering low glucose suspend (LGS)
Number of subjects: 144
Study 33098212 — intervention group
Group type: COMPARATOR
Intervention: Standard pump therapy with CGM initiation delayed for 6 months
Number of subjects: 144
Study 33098212 — intervention group
Group type: EXPERIMENTAL
Intervention: CGM adherence
Number of subjects: 144
Study 33275819 — intervention group
Group type: EXPERIMENTAL
Intervention: Selegiline and symptomatic treatment for iRBD
Number of subjects: 30
Study 33275819 — intervention group
Group type: COMPARATOR
Intervention: Symptomatic treatment only (Control)
Number of subjects: 30
Study 33232855 — intervention group
Group type: EXPERIMENTAL
Intervention: External focus (EF) instruction
Number of subjects: 19
Study 33232855 — intervention group
Group type: COMPARATOR
Intervention: Ankle bracing
Number of subjects: 19
Study 35150818 — intervention group
Group type: EXPERIMENTAL
Intervention: Barberry group (10 g/day dried purple-black barberry powder, once daily for 2 months)
Number of subjects: 84
Study 35150818 — intervention group
Group type: COMPARATOR
Intervention: Placebo group
Number of subjects: 84
Study 32443950 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness-based Exposure for PAP-associated Claustrophobia
Number of subjects: 0
Study 32164669 — intervention group
Group type: EXPERIMENTAL
Intervention: Training home care teams on interprofessional shared decision-making (IP-SDM)
Number of subjects: 271
Study 35930740 — intervention group
Group type: EXPERIMENTAL
Intervention: Informed consent language with none of GINA's limitations highlighted
Number of subjects: 1195
Study 35930740 — intervention group
Group type: COMPARATOR
Intervention: Informed consent language with various gaps in GINA highlighted
Number of subjects: 1195
Study 35930740 — intervention group
Group type: EXPERIMENTAL
Intervention: Informed consent language with the most information about limitations
Number of subjects: 1195
Study 32969197 — intervention group
Group type: EXPERIMENTAL
Intervention: Lifestyle intervention (LS) with cognitive behavioral therapy, nutrition advice, and exercise
Number of subjects: 183
Study 32969197 — intervention group
Group type: EXPERIMENTAL
Intervention: Lifestyle intervention (LS) with cognitive behavioral therapy, nutrition advice, exercise, and SMS
Number of subjects: 183
Study 32969197 — intervention group
Group type: COMPARATOR
Intervention: Care as usual (CAU)
Number of subjects: 183
Study 35780511 — intervention group
Group type: EXPERIMENTAL
Intervention: Treatment completers
Number of subjects: 59
Study 35780511 — intervention group
Group type: EXPERIMENTAL
Intervention: Elevated autistic characteristics
Number of subjects: 59
Study 35780511 — intervention group
Group type: EXPERIMENTAL
Intervention: High autistic characteristics
Number of subjects: 59
Study 615918992 — intervention group
Group type: COMPARATOR
Intervention: Transcorneal electrical stimulation (TES) at 150% of individual EPTs, n = 15
Number of subjects: 52
Study 615918992 — intervention group
Group type: COMPARATOR
Intervention: Transcorneal electrical stimulation (TES) at 200% of individual EPTs, n = 17
Number of subjects: 52
Study 615918992 — intervention group
Group type: COMPARATOR
Intervention: Sham stimulation, n = 20
Number of subjects: 52
Study 33962565 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine (loading dose 0.6 µg/kg in 10 min before anaesthesia induction, followed by continuous infusion 0.5 µg/kg/hr until 1 hour before end of surgery)
Number of subjects: 609
Study 33962565 — intervention group
Group type: COMPARATOR
Intervention: Control (volume-matched normal saline)
Number of subjects: 609
Study 33962565 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine
Number of subjects: 609
Study 33962565 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 609
Study 32558989 — intervention group
Group type: EXPERIMENTAL
Intervention: Danicamtiv (50–100 mg twice daily for 7 days)
Number of subjects: 40
Study 32558989 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40